Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic state coupled with a
unique CT or MR imaging appearance. Recognized in the setting of a number of complex …

The terms posterior reversible leukoencephalopathy, reversibleposterior cerebral edema
syndrome, and posterior reversibleencephalopathy syndrome (PRES) all refer to a …

Background Reversible posterior leukoencephalopathy syndrome (RPLS) is characterized
by neuroimaging findings of reversible vasogenic subcortical edema without infarction. The …

BACKGROUND AND PURPOSE: The recently described posterior reversible
encephalopathy syndrome (PRES) classically consists of reversible vasogenic edema in the …

Background. Urea cycle disorders (UCD) have a poor prognosis despite dietary and
pharmacologic therapy, especially if the onset of the disease is within the neonatal period …

Tacrolimus‐associated posterior reversible encephalopathy syndrome (PRES) is a potential
complication of allogeneic stem cell transplant (SCT). Due to the paucity of information on …

Purpose The aim of this retrospective study was to clarify the relation between the
reversibility of posterior reversible encephalopathy syndrome (PRES) with three factors: the …

Materials and methods A total of 39 patients diagnosed with preeclampsia (n= 30) and
eclampsia (n= 9) between 2000-2003 composed the study group. Ten of the patients were …

The pharmacological treatment of systemic lupus erythematosus (SLE) aims to decrease
disease activity, progression, systemic compromise, and mortality. Among the …

Background: Tacrolimus (FK506, Prograf) is a potent immunosuppressant, which inhibits
cytokine synthesis and blocks T-cell development. Optic neuropathy from tacrolimus toxicity …